Author response for "Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study"
Maartje E. Meier(Leiden University Medical Center), Natasha M. Appelman‐Dijkstra(Leiden University Medical Center), Elizabeth M. Winter(Leiden University Medical Center), Annenienke C. van de Ven(Radboud University Nijmegen), Stance N. Clerkx(Leiden University Medical Center), Alberto M. Pereira(Amsterdam Neuroscience), Michiel A. J. van de Sande(Leiden University Medical Center)
Cited by 0
Related Papers
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
|The Lancet|2019|472
Acromegaly
|Nature Reviews Disease Primers|2019|387
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351